Liang Min, Li Xiaocai, Xie Shangyu, Huang Xiaoying, Tan Shifan
Department of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.
Center of Respiratory Research, Maoming People's Hospital, Maoming, China.
Cancer Control. 2025 Jan-Dec;32:10732748251357449. doi: 10.1177/10732748251357449. Epub 2025 Jun 30.
IntroductionCombined with the characteristics of adenocarcinoma and squamous cell carcinoma, lung adenosquamous carcinoma (ASC) is an uncommon histological subtype of lung cancer with more aggressive biological behavior. This study aimed to quantify the 90-day mortality rate in patients with ASC, identify associated features, and develop a predictive machine learning model.MethodsThis retrospective study obtained data from the Surveillance, Epidemiology, and End Results (SEER) program database, covering the period from 2000 to 2018. Through univariate logistic regression and Lasso analyses, significant prognostic features were determined. We developed predictive models using XGBoost, logistic regression, and AJCC staging algorithms, assessing their performance via metrics such as the Area Under the Receiver Operating Characteristic Curve (AUC), Decision Curve Analysis (DCA), Kolmogorov-Smirnov (KS) statistic, and calibration plots. Restricted Cubic Splines (RCS) were employed to assess potential non-linear relationships between continuous features and survival outcomes.ResultsOur analysis of 2820 eligible patients identified 6 clinical features significantly affecting outcomes. The XGBoost model exhibited exceptional discriminatory power, with AUC scores of 0.97 in the training set and 0.84 in the validation set, surpassing other models in all datasets according to AUC, KS score, DCA, and calibration analyses. RCS analysis showed a non-linear association between tumor size and prognosis, with a cutoff size of 44 mm. Moreover, we integrated the model into a web-based platform to enhance its accessibility.ConclusionsWe present a novel machine learning model, supported by an easily accessible web-based platform, to guide personalized clinical decision-making and optimize treatment strategies for patients with ASC.
引言
肺腺鳞癌(ASC)结合了腺癌和鳞癌的特征,是一种罕见的肺癌组织学亚型,具有更具侵袭性的生物学行为。本研究旨在量化ASC患者的90天死亡率,识别相关特征,并开发一种预测性机器学习模型。
方法
这项回顾性研究从监测、流行病学和最终结果(SEER)计划数据库中获取数据,涵盖2000年至2018年期间。通过单因素逻辑回归和套索分析确定显著的预后特征。我们使用XGBoost、逻辑回归和美国癌症联合委员会(AJCC)分期算法开发预测模型,并通过受试者操作特征曲线下面积(AUC)、决策曲线分析(DCA)、柯尔莫哥洛夫-斯米尔诺夫(KS)统计量和校准图等指标评估其性能。采用限制立方样条(RCS)评估连续特征与生存结果之间的潜在非线性关系。
结果
我们对2820例符合条件的患者进行分析,确定了6个显著影响预后的临床特征。XGBoost模型表现出卓越的区分能力,训练集的AUC分数为0.97,验证集的AUC分数为0.84,根据AUC、KS分数、DCA和校准分析,在所有数据集中均优于其他模型。RCS分析显示肿瘤大小与预后之间存在非线性关联,临界大小为44毫米。此外,我们将该模型集成到一个基于网络的平台上,以提高其可及性。
结论
我们提出了一种新型机器学习模型,并辅以易于访问的基于网络的平台,以指导ASC患者的个性化临床决策并优化治疗策略。